Cuenta de resultados
THERAPEUTICSMD, INC.
TXMD
Resumen del rendimiento
Haga clic en cualquier fila de la tabla para añadirla al gráfico
en millones de USD
| Métrica | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ingresos
|
- | 1.76 | 1.30 | 69.96 | 86.95 | 64.87 | 49.65 | 16.10 | 16.78 | 19.36 | 20.14 | 15.03 | 8.78 | 3.82 | 2.09 |
|
Coste de los ingresos
|
- | - | 0.00 | 1.40 | 18.84 | 15.97 | 6.33 | 2.74 | - | - | - | - | - | - | - |
|
Beneficio bruto
|
- | 1.76 | 1.30 | 68.57 | 68.11 | 48.90 | 43.31 | 13.36 | 14.14 | 15.17 | 15.64 | 11.35 | 6.82 | 2.47 | 1.14 |
|
Gastos operativos
|
7.41 | 6.52 | 9.83 | 67.38 | 207.88 | 204.44 | 194.52 | 143.58 | 91.77 | 105.42 | 100.83 | 65.40 | 32.62 | 18.62 | 6.57 |
|
Investigación y desarrollo
|
- | - | - | - | 7.09 | 10.43 | 19.79 | 27.30 | 33.85 | 53.94 | 72.04 | 43.22 | 13.55 | 4.49 | 0.11 |
|
Ventas, generales y administrativos
|
6.85 | 4.74 | 8.90 | 57.90 | 108.20 | 192.96 | 174.11 | 115.99 | 57.70 | 51.35 | 28.72 | 22.12 | 19.01 | 14.07 | 6.41 |
|
Otros gastos operativos
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Resultado de explotación
|
-7.41 | -4.76 | -8.52 | 1.19 | -139.77 | -155.54 | -151.21 | -130.22 | -77.63 | -90.25 | -85.19 | -54.04 | -25.81 | -16.15 | -5.43 |
|
Ingresos no operativos
|
3.74 | 2.42 | 0.78 | -0.12 | -32.65 | -27.98 | -24.94 | -2.40 | 0.70 | 0.38 | 0.11 | -0.18 | -2.61 | -18.97 | -7.49 |
|
Ingresos por intereses
|
0.15 | 0.14 | - | - | - | - | - | - | - | 0.01 | 0.02 | 0.04 | 0.03 | - | - |
|
Gastos por intereses
|
0.01 | 0.01 | 0.30 | 36.07 | 32.92 | 28.58 | 17.38 | 4.41 | - | - | - | 1.17 | 1.17 | 0.30 | 0.06 |
|
Otros ingresos/gastos no operativos
|
- | - | - | -0.12 | - | - | - | - | - | - | - | - | - | - | - |
|
Resultado antes de impuestos
|
-0.65 | -2.34 | -7.74 | 1.07 | -172.42 | -183.52 | -176.14 | -132.62 | -76.93 | -89.88 | -85.08 | -54.22 | -28.42 | -35.12 | -12.91 |
|
Gasto por impuesto sobre beneficios
|
-0.08 | -0.16 | 2.54 | -110.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Participaciones no dominantes
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Beneficio neto
|
-0.57 | -2.18 | -10.28 | 112.00 | -172.42 | -183.52 | -176.14 | -132.62 | -76.93 | -89.88 | -85.08 | -54.22 | -28.42 | -35.12 | -12.91 |
Información complementaria
Datos por acción, partidas derivadas y otras – no forman parte de la cuenta de resultados
en millones de USD, salvo que se indique lo contrario
| Métrica | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciación y amortización
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-7.03 | -4.25 | -7.60 | 2.38 | -135.68 | -154.50 | -150.59 | -129.93 | -77.42 | -90.12 | -85.13 | -53.99 | -25.75 | -16.09 | -5.37 |
|
Beneficio por acción (básico)
|
-0.05 | -0.19 | -0.98 | 12.41 | - | - | - | - | - | - | - | - | - | - | - |
|
BPA diluido
|
-0.05 | -0.19 | -0.98 | 11.96 | - | - | - | - | - | - | - | - | - | - | - |
|
Promedio ponderado de acciones
|
11.57 | 0.01 | 10.44 | 9.03 | 397.99 | - | - | - | - | - | - | - | - | - | - |
|
Promedio ponderado diluido de acciones
|
11.57 | 0.01 | 10.44 | 9.37 | - | - | - | - | - | - | - | - | - | - | - |
|
Resultado global
|
- | - | -10.28 | 112.00 | -172.42 | - | - | - | - | - | - | - | - | - | - |